Ceftriaxone and Altace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftriaxone (ceftriaxone sodium) and Altace (ramipril). Common drug interactions include fear among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Altace. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.



On Jul, 09, 2026

33 people who take Ceftriaxone and Altace together, and have interactions are studied.

Ceftriaxone and Altace drug interactions.

What are the common drug interactions of Ceftriaxone and Altace, by gender? *:

female:

  1. Fear
  2. Injury
  3. Multi-organ failure (multisystem organ failure)
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Renal impairment (severely reduced kidney function)
  7. Renal injury (kidney injury)
  8. Stress
  9. Asthma
  10. Hair disorder

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal failure acute (rapid kidney dysfunction)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Visual impairment
  6. Headache (pain in head)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Cardiac murmur (an heart sound in valve abnormality)
  9. Congestive cardiomyopathy (weakening of heart muscle)
  10. Cough

What are the common drug interactions of Ceftriaxone and Altace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chest pain
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Mobility decreased (ability to move is reduced)
  4. Headache (pain in head)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Emotional distress
  10. Fear

50-59:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Back pain
  3. Bile duct necrosis
  4. Blood alkaline phosphatase increased
  5. Blood bilirubin increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cardiac arrest
  8. Cardiac failure congestive
  9. Cellulitis (infection under the skin)
  10. Cerebral artery embolism (sudden blocking of an artery by a clot or foreign material)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Visual impairment
  5. Emotional distress
  6. Injury
  7. Asthma
  8. Cardiac murmur (an heart sound in valve abnormality)
  9. Congestive cardiomyopathy (weakening of heart muscle)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 18.18%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 12.12%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 12.12%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 9.09%
  5. Bronchitis Acute (acute inflammation of the mucous membrane in the bronchial tubes): 3 people, 9.09%
  6. Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 2 people, 6.06%
  7. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 6.06%
  8. High Blood Cholesterol: 2 people, 6.06%
  9. Hair Disorder: 2 people, 6.06%
  10. Adenoid Cystic Carcinoma (cancer that can exist in many different body sites): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and Altace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ceftriaxone and Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftriaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Altace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium and ramipril (the active ingredients of Ceftriaxone and Altace, respectively), and Ceftriaxone and Altace (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: